产品封面图

上皮间质细胞转化 ChIP PCR 芯片Epithelial

to Mesenchymal Transition (EMT) ChIP PCR Array
收藏
  • 询价
  • Epithelial to Mesenchymal Transition (EMT) ChIP PCR Array
  • 上海
  • 2026年01月09日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 服务名称

      Epithelial to Mesenchymal Transition (EMT) ChIP PCR Array

    • 提供商

      SAB

    Human Epithelial to Mesenchymal Transition (EMT) ChIP PCR Array
    The Human Epithelial to Mesenchymal Transition (EMT) EpiTect Chip qPCR Array profiles the histone modification status or “histone code” of 84 genes key to Epithelial to Mesenchymal Transition (EMT). Histone modifications define chromatin structure, thus playing a key role in the epigenetic-based regulation of gene expression. EMT and the reciprocal mesenchymal to epithelial transition (MET), both mediated by gene expression changes, are key processes involved in both tumor metastasis and stem cell differentiation and development. During EMT, epithelial cells lose apical/basolateral polarity, break intercellular tight junctions, and degrade basement membrane extracellular matrix components to become migratory mesenchymal cells. As such, the array represents cell surface receptor, extracellular matrix, and cytoskeletal genes mediating cell adhesion, migration, motility, and morphogenesis; genes controlling cell differentiation, development, growth, and proliferation; as well as signal transduction and transcription factor genes that cause EMT and all of its associated processes. The results can help you provide further insights into the role of histone modifications in regulating EMT-dependent tumor metastasis and stem cell differentiation and development. Using chromatin immunoprecipitation and this real-time PCR Array, your research study can easily and reliably analyze the histone modification patterns associated with a focused gene panel involved in EMT.
    The EpiTect Chip qPCR Arrays are intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.
    Genes Up-Regulated During EMT: AHNAK, BMP1, CALD1, CDH2 (N-cadherin), COL1A2, COL3A1, COL5A2, FN1, FOXC2, GNG11, GSC, IGFBP4, ITGA5, ITGAV, MMP2 (Gelatinase A), MMP3, MMP9 (Gelatinase B), MSN, SERPINE1 (PAI-1), SNAI1, SNAI2, SNAI3, SOX10, SPARC, STEAP1, TCF4, TIMP1, TMEFF1, TMEM132A, TWIST1, VCAN, VIM, VPS13A, WNT5A, WNT5B.
    Genes Down-Regulated During EMT: CAV2, CDH1 (E-cadherin), DSP, FGFBP1, IL1RN, KRT19, MITF, MST1R, NUDT13, PPPDE2, RGS2, SPP1 (Osteopontin), TFPI2, TSPAN13.
    Genes with Known Histone Modifications during EMT:
    Increased H3K4me3: AHNAK, AKT1, BMP1, CALD1, CAV2, CDH2 (N-cadherin), CTNNB1, FN1, FZD7, GNG11, GSK3B, IGFBP4, ILK, ITGA5, MAP1B, MITF, MMP2 (Gelatinase A), RGS2, SERPINE1 (PAI-1), SNAI1, SNAI2, SPARC, TCF4, TGFB1, TGFB2, TGFB3, TIMP1, TMEFF1, TSPAN13, VIM, VPS13A, WNT5A.
    Decreased H3K27me3: DSP, FGFBP1, GSC, IL1RN.
    Differentiation & Development: AKT1, BMP1, BMP2, BMP7, COL3A1, COL5A2, CTNNB1, DSP, ERBB3, F11R, FOXC2, FZD7, GSC, KRT14, MITF, MST1R, NODAL, NOTCH1, PTP4A1, SMAD2, SNAI1, SNAI2, SOX10, TGFB2, TGFB3, TMEFF1, TWIST1, VCAN, WNT11, WNT5A, WNT5B.
    Morphogenesis: CTNNB1, FOXC2, PPP3R1, RAC1, SMAD2, SNAI1, SOX10, TGFB1, TGFB2, TGFB3, TWIST1, WNT11, WNT5A.
    Cell Growth & Proliferation: AKT1, BMP1, BMP2, BMP7, CAV2, CTNNB1, EGFR, ERBB3, FGFBP1, FOXC2, HIF1A, IGFBP4, ILK, MST1R, NODAL, PDGFRB, TGFB1, TGFB2, TGFB3, TIMP1, VCAN.
    Migration & Motility: CALD1, CAV2, EGFR, FN1, ITGB1, MSN, MST1R, NODAL, PDGFRB, RAC1, STAT3, TGFB1, VIM.
    Cytoskeleton: CAV2, KRT7, MAP1B, PLEK2, RAC1, VIM.
    Extracellular Matrix & Cell Adhesion: BMP1, BMP2, BMP7, CDH1 (E-cadherin), CDH2 (N-cadherin), COL1A2, COL3A1, COL5A2, CTGF, CTNNB1, DSC2, EGFR, ERBB3, F11R, FN1, FOXC2, ILK, ITGA5, ITGAV, ITGB1, MMP2 (Gelatinase A), MMP3, MMP9 (Gelatinase B), PTK2, RAC1, SERPINE1 (PAI-1), SPP1 (Osteopontin), TGFB1, TGFB2, TIMP1, VCAN.
    Signaling Pathways:
    Estrogen Receptor: CAV2, ESR1 (ERa), KRT19, TGFB3.
    G-Protein Coupled Receptor: AKT1, FZD7, GNG11, RAC1, RGS2.
    Integrin-Mediated: COL3A1, CTGF, ILK, ITGA5, ITGAV, ITGB1, PTK2.
    Notch: FOXC2, NOTCH1.
    Receptor Tyrosine Kinase: EGFR, ERBB3, PDGFRB, RGS2, SPARC.
    TGFb / BMP: BMP1, BMP2, BMP7, COL3A1, SMAD2, SMAD4, TGFB1, TGFB2, TGFB3.
    WNT: CTNNB1, FZD7, GSK3B, WNT11, WNT5A, WNT5B.
    Transcription Factors: CTNNB1, ESR1 (ERa), FOXC2, GSC, MITF, NOTCH1, SIP1, SMAD2, SNAI2, SNAI3, SOX10, STAT3, TCF4, TWIST1, ZEB2.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 基因芯片实验原理与方法(一)

      的集成化正在使生命科学的研究和应用发生一场革命。根据固定在芯片载体上的核酸分子的不同,基因芯片可以分为cDNA芯片和寡核昔酸芯片等。寡核昔酸芯片主要基于光引导聚合技术,该技术是Affymetrix公司开发的专利技术,由于其突出的优点,正得到越来越广泛的应用。二、原理基因芯片(Gene Chip,DNA Chip),又称DNA微阵列(DNA Micorarray),是指按照预定位置固定在固相载体上很小面积内的千万个核酸分子所组成的微点阵阵列。在一定条件下,载体上的核酸分子可以与来自样品的序列互补的核酸

    • 生物芯片入门(三):基因表达谱芯片实验操作1

      ,或者用RNase-Free的DNase处理RNA样品。在这里我们介绍一些常用的RNA纯化试剂盒,特别是由Affymetrix公司推荐的QIAGEN RNA纯化系列。* RNeasy Protect Kit:一旦生物样品被收集分离,它的RNA会立刻变得非常不稳定,极易被降解。由于特异及非特异的RNA降解,或者由于应激反应产生新的RNA都会引起RNA状态的改变。对于生物芯片、基因表达矩阵分析(Array Analysis)、定量RT-PCR等实验来说,采样后立即稳定样品里的RNA以保存当时RNA的表达状态,是精确

    • 【求助】什么是micro-array analysis,怎么翻译?

      and Design of Micro-array PCR Chip Scanner 微阵列PCR基因芯片扫描仪的研制 Image Signal Acquisition System for SPR Micro-Array Based on Phase Detection SPR微阵列相位检测图像信息采集系统研究 Development of Imaging SPR Analyzer and Its Micro-array

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥5000
    上海伯豪生物技术有限公司
    2026年01月04日询价
    询价
    上海吉凯基因医学科技股份有限公司
    2026年01月10日询价
    询价
    上海芯超生物科技有限公司
    2025年12月24日询价
    上皮间质细胞转化 ChIP PCR 芯片Epithelial to Mesenchymal Transition (EMT) ChIP PCR Array
    询价